Non-transferrin-bound iron in haematological patients during chemotherapy and conditioning for autologous stem cell transplantation

被引:33
|
作者
Sahlstedt, Leila [1 ]
von Bonsdorff, Leni [2 ]
Ebeling, Freja [1 ]
Parkkinen, Jaakko [2 ,3 ]
Juvonen, Eeva [1 ]
Ruutu, Tapani [1 ]
机构
[1] Univ Helsinki, Cent Hosp, Dept Med, Helsinki, Finland
[2] Finnish Red Cross & Blood Transfus Serv, SF-00310 Helsinki, Finland
[3] Univ Helsinki, Cent Hosp, HUSLAB Lab Serv, Helsinki, Finland
关键词
non-transferrin-bound iron; iron; transferrin saturation; chemotherapy; autologous stem cell transplantation; METABOLISM;
D O I
10.1111/j.1600-0609.2009.01310.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Free iron induced hydroxyl radical formation is one possible mechanism for tissue injury during cytotoxic therapy. We studied the appearance of free, non-transferrin-bound iron (NTBI) at baseline and during the 20-d period after the onset of cytotoxic chemotherapy in patients with haematological malignancy undergoing intensive chemotherapy or conditioning for autologous stem cell transplantation (aSCT). NTBI was detected on average for 15.6 d in patients treated with chemotherapy only, and for 6.1 d in patients undergoing aSCT. The recovery of the bone marrow function coincided with the disappearance of NTBI. The type of the conditioning regimen was also associated with the appearance of NTBI. The timing of the presence of NTBI accords with the presence of the most important non-infectious complication of intensive chemotherapy and autologous transplantation, mucosal injury, and free iron is likely to contribute to this and probably other complications of the intensive treatments.
引用
收藏
页码:455 / 459
页数:5
相关论文
共 50 条
  • [41] Angiotensin II inhibits uptake of transferrin-bound iron but not non-transferrin-bound iron by cultured astrocytes
    Huang, Suna
    Du, Fang
    Li, Lan
    Liu, Yong
    Liu, Yuhong
    Zhang, Chao
    Qian, Zhong Ming
    NEUROPEPTIDES, 2014, 48 (03) : 161 - 166
  • [42] Lack of Non-Transferrin-Bound Iron in Heart Transplant Recipients
    Przybylowski, P.
    Malyszko, J.
    Levin-Iaina, N.
    Malyszko, J. S.
    TRANSPLANTATION PROCEEDINGS, 2011, 43 (08) : 3068 - 3070
  • [43] NON-TRANSFERRIN-BOUND IRON UPTAKE BY ISOLATED RAT HEPATOCYTES
    BARISANI, D
    BERG, CL
    WESSLINGRESNICK, M
    GOLLAN, JL
    GASTROENTEROLOGY, 1994, 106 (04) : A864 - A864
  • [44] Is myocardial accumulation of non-transferrin-bound iron clinically relevant?
    von Haehling, Stephan
    Sato, Ryosuke
    Anker, Stefan D.
    EUROPEAN HEART JOURNAL, 2024, 45 (42) : 4509 - 4511
  • [45] Effects of intravenous polymaltose iron on oxidant stress and non-transferrin-bound iron in hemodialysis patients
    Driss, F
    Vrtovsnik, F
    Katsahian, S
    Michel, C
    Baron, G
    Kolta, A
    Sedrati, N
    Mentré, F
    Mignon, F
    Cabantchik, I
    Grandchamp, B
    NEPHRON CLINICAL PRACTICE, 2005, 99 (03): : C63 - C67
  • [46] PROPERTIES AND HEPATIC-METABOLISM OF NON-TRANSFERRIN-BOUND IRON
    BATEY, RG
    SHAMIR, S
    WILMS, J
    DIGESTIVE DISEASES AND SCIENCES, 1981, 26 (12) : 1084 - 1088
  • [48] Effects of overexpression of the transferrin receptor on the rates of transferrin recycling and uptake of non-transferrin-bound iron
    Callus, BA
    Iacopetta, BJ
    Kuhn, LC
    Morgan, EH
    EUROPEAN JOURNAL OF BIOCHEMISTRY, 1996, 238 (02): : 463 - 469
  • [49] Common presence of non-transferrin-bound iron among patients with type 2 diabetes
    Lee, DH
    Liu, DY
    Jacobs, DR
    Shin, HR
    Song, K
    Lee, IK
    Kim, B
    Hider, RC
    DIABETES CARE, 2006, 29 (05) : 1090 - 1095
  • [50] Vitamin E correlates inversely with non-transferrin-bound iron in sickle cell disease
    Marwah, SS
    Wheelwright, D
    Blann, AD
    Rea, C
    Beresford, R
    Phillips, JD
    Wright, J
    Bareford, D
    BRITISH JOURNAL OF HAEMATOLOGY, 2001, 114 (04) : 917 - 919